Anti-angiogenic peptides application in cancer therapy; a review
Cancer is a disease advanced via surplus angiogenesis. The development of new anti-
angiogenic therapeutic agents with more efficacy and fewer side effects is still quite …
angiogenic therapeutic agents with more efficacy and fewer side effects is still quite …
Protein corona gold nanoparticles fingerprinting reveals a profile of blood coagulation proteins in the serum of Her2-overexpressing breast cancer patients
MP Chantada-Vazquez, A Castro Lopez… - International Journal of …, 2020 - mdpi.com
Breast cancer (BC) is a molecularly heterogeneous disease that encompasses five major
molecular subtypes (luminal A (LA), luminal B HER2 negative (LB-), luminal B HER2 …
molecular subtypes (luminal A (LA), luminal B HER2 negative (LB-), luminal B HER2 …
[PDF][PDF] Potential protein biomarker discovery for gallbladder cancer in a South African cohort
P Baichan - 2023 - wiredspace.wits.ac.za
I, Pavan Baichan, declare that this thesis entitled “Potential protein biomarker discovery for
gallbladder cancer in a South African cohort” is my own, unaided work. It is being submitted …
gallbladder cancer in a South African cohort” is my own, unaided work. It is being submitted …
The role of platelet microparticles in the production of antibodies from B lymphocytes against HLA-DR antigen in vitro
Z Khayati, F Yari - Iranian Journal of Pediatric …, 2019 - publish.kne-publishing.com
Background: Platelets can activate B cells and stimulate them for the production of
antibodies. Since platelet microparticles (PMPs) originate from platelets, they may have the …
antibodies. Since platelet microparticles (PMPs) originate from platelets, they may have the …
[HTML][HTML] An affinity-based method for the purification of platelet factor 4 from outdated platelet concentrates
A Goodarzi, F Yari… - Journal of Research in …, 2023 - ijrabms.umsu.ac.ir
Platelet factor 4 (PF4) or CXCL4 is one of the major platelet chemokines which is released
upon platelet activation. Its amino acid sequence was identified in 1977 by Deuel and …
upon platelet activation. Its amino acid sequence was identified in 1977 by Deuel and …
Application of Nanotechnology for the Discovery of Circulating Proteins as Novel Biomarkers of Breast Cancer
A Castro López - 2021 - ruc.udc.es
Breast cancer is one of the most common cancers in women and accounts for about 14% of
cancer-related deaths in females around the world. Breast cancer is a heterogeneous …
cancer-related deaths in females around the world. Breast cancer is a heterogeneous …